Sharon L Bober is an expert in Oncology at Dana-Farber Cancer Institute (United States). Sharon L Bober has authored 103 publications, the most recent in 2026, and is an investigator in 3 clinical trials, 1 of them ongoing. SLR score: 398 (community average: 125). How the SLR is computed.

LeadR Profile

Sharon L Bober Dana-Farber Cancer Institute United States
398 ScienceLeadR Reputation 398
Network Map

Oncology

Subspecialties: Transplantation - Hematology - Gynecology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2004 - 2026

Source: PubMed

Dana-Farber Cancer Institute

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 103

Citations

Citations: 2 935 1st author: 22 Last author: 37 Unique author: 2


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Sexual inactivity in young adult survivors of childhood cancer: a Project REACH study.
PMID 42932166 — cancer survivors, neoplasms, sex, diagnosis
J Cancer Surviv20260
Educating Pediatric Oncology Clinicians on Sexual Health Care for Adolescents and Young Adults With Cancer: Results From a Proof-of-Concept Study.
PMID 42900854 — communication, neoplasms, proof of concept study, adolescent, surveys and questionnaires, retention, psychology, education, benchmarking
JCO Oncol Pract20260
Initial Development of a Brief Mind-Body Sexual Well-Being Program for Female Colorectal and Anal Cancer Survivors: A Two-Phase Study of Survivor Needs and Treatment Preferences.
PMID 42495181 — feedback, cancer survivors, anus neoplasms, neoplasms, therapeutics, colorectal neoplasms, psychosocial intervention
Glob Adv Integr Med Health20260
Update on curriculum standards for sexual health education, impact, and platforms for medical training: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024).
PMID 42485646 — sexually transmitted diseases, curriculum, schools, health occupations, occupations, research, health education, schools, medical, artificial intelligence, education
Sex Med Rev20260
AYA POWER: Feasibility and Early Outcomes of a Global Virtual AYA Oncology Education Curriculum.
PMID 42455153 — neoplasms, curriculum, adolescent, education
J Adolesc Young Adult Oncol20260

Clinical Studies 3

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 3

By status:

Completed 2
Active not recruiting 1

By type:

Interventional 3

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 1
multicentric5to9 0
multicentricup10 0

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
The Transitions Project Efficacy Trial
NCT05087251 — quality of life, lung, neoplasms, uncertainty, interpersonal relations, lung neoplasms, therapeutics
N/AActive not recruiting2021

LeadR Networks

Main global connection map